These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35274813)
1. m Zheng H; Zhu M; Li W; Zhou Z; Wan X Liver Int; 2022 May; 42(5):1144-1157. PubMed ID: 35274813 [TBL] [Abstract][Full Text] [Related]
2. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2. Li J; Jiang X; Xu Y; Kang P; Huang P; Meng N; Wang H; Zheng W; Wang H; Wang Z; Zhong X; Cui Y Int J Biol Sci; 2022; 18(11):4301-4315. PubMed ID: 35864972 [TBL] [Abstract][Full Text] [Related]
3. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p. Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis. Chang W; Wang Y; Li W; Geng Z Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660 [TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis. Sun ZP; Tan ZG; Peng C; Yi WM J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226 [TBL] [Abstract][Full Text] [Related]
6. lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p. Jiang H; Li W; Xue Z; Chen W; Zhao L; Song H; Hou J Clin Res Hepatol Gastroenterol; 2022; 46(7):101915. PubMed ID: 35346892 [TBL] [Abstract][Full Text] [Related]
7. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis. Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758 [TBL] [Abstract][Full Text] [Related]
8. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis. Jiang T; Wang C; Zhu Y; Han H J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299 [TBL] [Abstract][Full Text] [Related]
9. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN. Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725 [TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis. Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683 [TBL] [Abstract][Full Text] [Related]
11. LncRNA LINC01061 sponges miR-612 to regulate the oncogenic role of SEMA4D in cholangiocarcinoma. Yu A; Zhao L; Kang Q; Chen K; Li J; Fu H; Liu J; Zhang X Biochem Biophys Res Commun; 2019 May; 513(2):465-471. PubMed ID: 30967271 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma. Li D; Tang Z; Gao Z; Shen P; Liu Z; Dang X Mol Cell Biol; 2020 Jul; 40(15):. PubMed ID: 32423991 [TBL] [Abstract][Full Text] [Related]
13. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma. Zhang L; Jiang G; Lu J; Wang L Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway. Hu X; Tan Z; Yang Y; Yang P J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284 [TBL] [Abstract][Full Text] [Related]
15. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p. Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332 [TBL] [Abstract][Full Text] [Related]
16. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691 [TBL] [Abstract][Full Text] [Related]
17. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients. Chen T; Wang H; Yan H Cell Cycle; 2022 Oct; 21(19):2079-2090. PubMed ID: 35670491 [TBL] [Abstract][Full Text] [Related]
18. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10. Liu Z; Pan L; Yan X; Duan X FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605 [TBL] [Abstract][Full Text] [Related]
19. The Interaction Between lncRNA SNHG1 and miR-140 in Regulating Growth and Tumorigenesis via the TLR4/NF-κB Pathway in Cholangiocarcinoma. Li Z; Li X; Du X; Zhang H; Wu Z; Ren K; Han X Oncol Res; 2019 Jun; 27(6):663-672. PubMed ID: 30764893 [TBL] [Abstract][Full Text] [Related]
20. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis. Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]